+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Psoriasis"

British Association of Dermatologists' Management Guidelines - Product Thumbnail Image

British Association of Dermatologists' Management Guidelines

  • Book
  • March 2011
  • 344 Pages
  • United Kingdom
Epigenetics and Dermatology - Product Thumbnail Image

Epigenetics and Dermatology

  • Book
  • February 2015
Loading Indicator

Psoriasis is a chronic skin condition that affects millions of people worldwide. It is characterized by red, scaly patches on the skin that can be itchy and painful. It is caused by an overactive immune system that triggers inflammation and rapid skin cell growth. Treatment for psoriasis typically involves topical medications, phototherapy, and systemic medications. The psoriasis market is a subset of the larger dermatology market. It is a rapidly growing market, driven by the increasing prevalence of psoriasis and the development of new treatments. The market is highly competitive, with a number of companies offering treatments for psoriasis. Some of the major companies in the psoriasis market include AbbVie, Amgen, Celgene, Janssen, Novartis, Pfizer, and UCB. These companies offer a range of treatments, including topical medications, phototherapy, and systemic medications. Show Less Read more